logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Von WÜlfing, Maximilian, Dr
    Born in February 1976
    Individual (1 offspring)
    Officer
    icon of calendar 2023-01-10 ~ now
    OF - Director → CIF 0
  • 2
    Slater, Mark Anthony
    Born in July 1976
    Individual (2 offsprings)
    Officer
    icon of calendar 2022-10-10 ~ now
    OF - Director → CIF 0
  • 3
    icon of address80, Pall Mall, London, England
    Active Corporate (8 parents, 8 offsprings)
    Person with significant control
    icon of calendar 2020-12-16 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
Ceased 3
  • 1
    Bowen, Craig Andrew
    General Manager born in August 1971
    Individual (2 offsprings)
    Officer
    icon of calendar 2019-09-27 ~ 2023-01-05
    OF - Director → CIF 0
  • 2
    Wiest, Daniel, Dr
    Accountant born in July 1963
    Individual
    Officer
    icon of calendar 2017-08-16 ~ 2018-04-06
    OF - Director → CIF 0
  • 3
    Koch, Jan Christoph
    Corporate Executive born in January 1974
    Individual
    Officer
    icon of calendar 2018-04-06 ~ 2023-01-05
    OF - Director → CIF 0
parent relation
Company in focus

NEURAXPHARM UK LIMITED

Previous name
NUPHARM UK HOLDING LIMITED - 2017-11-14
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Par Value of Share
Class 1 ordinary share
12024-01-01 ~ 2024-12-31
Turnover/Revenue
18,730,416 GBP2024-01-01 ~ 2024-12-31
19,931,286 GBP2023-01-01 ~ 2023-12-31
Cost of Sales
-15,498,844 GBP2024-01-01 ~ 2024-12-31
-16,410,887 GBP2023-01-01 ~ 2023-12-31
Gross Profit/Loss
3,231,572 GBP2024-01-01 ~ 2024-12-31
3,520,399 GBP2023-01-01 ~ 2023-12-31
Administrative Expenses
-4,143,879 GBP2024-01-01 ~ 2024-12-31
-2,901,795 GBP2023-01-01 ~ 2023-12-31
Operating Profit/Loss
-912,307 GBP2024-01-01 ~ 2024-12-31
618,604 GBP2023-01-01 ~ 2023-12-31
Interest Payable/Similar Charges (Finance Costs)
-242,288 GBP2024-01-01 ~ 2024-12-31
-231,438 GBP2023-01-01 ~ 2023-12-31
Profit/Loss on Ordinary Activities Before Tax
-1,154,595 GBP2024-01-01 ~ 2024-12-31
387,166 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
-871,400 GBP2024-01-01 ~ 2024-12-31
304,364 GBP2023-01-01 ~ 2023-12-31
Equity
Retained earnings (accumulated losses)
-489,447 GBP2024-12-31
381,953 GBP2023-12-31
77,589 GBP2022-12-31
Intangible Assets
236,422 GBP2024-12-31
400,460 GBP2023-12-31
Property, Plant & Equipment
246 GBP2024-12-31
1,012 GBP2023-12-31
Fixed Assets
236,668 GBP2024-12-31
401,472 GBP2023-12-31
Total Inventories
7,902,089 GBP2024-12-31
6,354,832 GBP2023-12-31
Debtors
4,999,502 GBP2024-12-31
5,222,527 GBP2023-12-31
Cash at bank and in hand
281,113 GBP2024-12-31
820,980 GBP2023-12-31
Current Assets
13,182,704 GBP2024-12-31
12,398,339 GBP2023-12-31
Creditors
Current
11,517,585 GBP2024-12-31
9,406,769 GBP2023-12-31
Net Current Assets/Liabilities
1,665,119 GBP2024-12-31
2,991,570 GBP2023-12-31
Total Assets Less Current Liabilities
1,901,787 GBP2024-12-31
3,393,042 GBP2023-12-31
Creditors
Non-current
2,086,234 GBP2024-12-31
2,706,089 GBP2023-12-31
Net Assets/Liabilities
-184,447 GBP2024-12-31
686,953 GBP2023-12-31
Equity
Called up share capital
305,000 GBP2024-12-31
305,000 GBP2023-12-31
Equity
-184,447 GBP2024-12-31
686,953 GBP2023-12-31
Wages/Salaries
1,421,224 GBP2024-01-01 ~ 2024-12-31
716,244 GBP2023-01-01 ~ 2023-12-31
Social Security Costs
160,530 GBP2024-01-01 ~ 2024-12-31
80,937 GBP2023-01-01 ~ 2023-12-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
13,024 GBP2024-01-01 ~ 2024-12-31
10,457 GBP2023-01-01 ~ 2023-12-31
Staff Costs/Employee Benefits Expense
1,594,778 GBP2024-01-01 ~ 2024-12-31
807,638 GBP2023-01-01 ~ 2023-12-31
Average Number of Employees
152024-01-01 ~ 2024-12-31
92023-01-01 ~ 2023-12-31
Director Remuneration
162,962 GBP2024-01-01 ~ 2024-12-31
159,916 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Depreciation Expense
Owned assets
980 GBP2024-01-01 ~ 2024-12-31
1,865 GBP2023-01-01 ~ 2023-12-31
Current Tax for the Period
82,802 GBP2023-01-01 ~ 2023-12-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
1,740,979 GBP2024-12-31
1,674,987 GBP2023-12-31
Development expenditure
35,728 GBP2024-12-31
35,728 GBP2023-12-31
Computer software
96,087 GBP2024-12-31
86,539 GBP2023-12-31
Intangible Assets - Gross Cost
1,872,794 GBP2024-12-31
1,797,254 GBP2023-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
1,524,068 GBP2024-12-31
1,298,976 GBP2023-12-31
Development expenditure
19,927 GBP2024-12-31
15,120 GBP2023-12-31
Intangible Assets - Accumulated Amortisation & Impairment
1,636,372 GBP2024-12-31
1,396,794 GBP2023-12-31
Intangible Assets - Increase From Amortisation Charge for Year
Patents/Trademarks/Licences/Concessions
225,092 GBP2024-01-01 ~ 2024-12-31
Development expenditure
4,807 GBP2024-01-01 ~ 2024-12-31
Intangible Assets - Increase From Amortisation Charge for Year
239,578 GBP2024-01-01 ~ 2024-12-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
216,911 GBP2024-12-31
376,011 GBP2023-12-31
Development expenditure
15,801 GBP2024-12-31
20,608 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
Computers
9,542 GBP2024-12-31
9,328 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Computers
9,296 GBP2024-12-31
8,316 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Computers
980 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment
Computers
246 GBP2024-12-31
1,012 GBP2023-12-31
Merchandise
7,902,089 GBP2024-12-31
6,354,832 GBP2023-12-31
Trade Debtors/Trade Receivables
Current
4,432,702 GBP2024-12-31
5,088,527 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
17,991 GBP2024-12-31
2,998 GBP2023-12-31
Amount of corporation tax that is recoverable
Current
124,214 GBP2024-12-31
Debtors - Deferred Tax Asset
Current
200,393 GBP2024-12-31
Prepayments
Current
224,202 GBP2024-12-31
126,325 GBP2023-12-31
Debtors
Amounts falling due within one year, Current
4,999,502 GBP2024-12-31
Current, Amounts falling due within one year
5,222,527 GBP2023-12-31
Trade Creditors/Trade Payables
Current
572,103 GBP2024-12-31
380,674 GBP2023-12-31
Amounts owed to group undertakings
Current
9,589,906 GBP2024-12-31
7,410,930 GBP2023-12-31
Corporation Tax Payable
Current
82,802 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
1,261,870 GBP2024-12-31
949,928 GBP2023-12-31
Amounts owed to group undertakings
Non-current
2,086,234 GBP2024-12-31
2,706,089 GBP2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
12,231 GBP2024-12-31
36,693 GBP2023-12-31
Between one and five year
12,231 GBP2023-12-31
All periods
12,231 GBP2024-12-31
48,924 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
305,000 shares2024-12-31
Profit/Loss
Retained earnings (accumulated losses)
-871,400 GBP2024-01-01 ~ 2024-12-31
  • NEURAXPHARM UK LIMITED
    Info
    NUPHARM UK HOLDING LIMITED - 2017-11-14
    Registered number 10918621
    icon of addressTudor House, 16 Cathedral Road, Cardiff CF11 9LJ
    PRIVATE LIMITED COMPANY incorporated on 2017-08-16 (8 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2024-08-15
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.